Move over, Hugh Laurie: there’s a new Dr. House in town. Harvard Medical School associate professor Marinka Zitnik and her lab announced the development of TxGNN, an artificial intelligence model ...

AI-driven drug repurposing presents opportunities through cost-effective drug development, personalized medicine, and ...

Imagine giving a familiar medication a whole new purpose—finding fresh treatments without starting from scratch. That’s precisely what a team of researchers at Xidian University in China has been ...

A team of U.S. clinicians has launched a first-of-its-kind observational study on how repurposed drugs with expired patents, such as ivermectin, might help in treating cancer. The study, led by the ...

Entod Pharmaceuticals has developed the world's first losartan eye drops to manage corneal scarring. It is still in clinical ...

Scientists from Harvard Medical School are using artificial intelligence (AI) to solve the problem of finding treatments for rare and neglected diseases. They have developed a new method, called TxGNN ...

New mouse studies show a repurposed drug and intranasal insulin improved memory, reduced brain inflammation, and aided ...

A research team reports a promising new strategy: combining two already-approved drugs—silybin, a natural liver-protective ...

“The AWP may be determined by several different methods. The drug manufacturer may report the AWP to the individual publisher of drug pricing data, such as Medi-Span. The AWP may also be calculated by ...